Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
3
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(1)
Other(2)

Detailed Status

unknown2
Completed1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

completed133%
unknown267%

Recent Activity

0 active trials
Showing 3 of 3
unknownnot_applicable

Clinical Of Chocolate Balloon Dilatation Versus Plain Balloon Dilatation to Treat Arteriosclerosis Occlusive Disease of Lower Extremity

NCT05158283
unknownnot_applicable

Sirolimus Coated Angioplasty Versus Plain Balloon Angioplasty

NCT04409912
completednot_applicable

Drug-Eluting Balloon in Arteriovenous Graft

NCT03388892

Clinical Trials (3)

Showing 3 of 3 trials
NCT05158283Not Applicable

Clinical Of Chocolate Balloon Dilatation Versus Plain Balloon Dilatation to Treat Arteriosclerosis Occlusive Disease of Lower Extremity

Unknown
NCT04409912Not Applicable

Sirolimus Coated Angioplasty Versus Plain Balloon Angioplasty

Unknown
NCT03388892Not Applicable

Drug-Eluting Balloon in Arteriovenous Graft

Completed

All 3 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
3